<DOC>
	<DOCNO>NCT00923702</DOCNO>
	<brief_summary>The primary study hypothesis two-dose human papillomavirus ( HPV ) vaccine regimen would offer similar immunogenicity protection three-dose regimen girl persistent HPV infection cervical neoplasia cause HPV type include vaccine .</brief_summary>
	<brief_title>Trial Two Versus Three Doses Human Papillomavirus ( HPV ) Vaccine India</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Apparently healthy , ambulant girl age 10 18 year Unmarried girls Girls intact uterus Resident village choose study Girls severe and/or debilitate illness Past history allergy medication</criteria>
	<gender>Female</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>